uPA and PAI-1 in Rectal Cancer—Relationship to Radiotherapy and Clinical Outcome
Authors:
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Journal of Surgical Research
- Vol. 153 (1) , 46-53
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical useEuropean Journal of Cancer, 2007
- Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trialsBritish Journal of Cancer, 2007
- ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal CancerJournal of Clinical Oncology, 2006
- Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiationScandinavian Journal of Gastroenterology, 2006
- Swedish Rectal Cancer Trial: Long Lasting Benefits From Radiotherapy on Survival and Local Recurrence RateJournal of Clinical Oncology, 2005
- Radiation and Transforming Growth Factor-β Cooperate in Transcriptional Activation of the Profibrotic Plasminogen Activator Inhibitor-1 GeneClinical Cancer Research, 2005
- Historical analysis of PAI-1 from its discovery to its potential role in cell motility and diseaseThrombosis and Haemostasis, 2005
- The plasminogen activator and matrix metalloproteinase systems in colorectal cancerEuropean Journal of Cancer, 2003
- Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progressionMolecular Pathology, 2000
- Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancerThe Lancet, 1994